CLGN — CollPlant Biotechnologies Ltd
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1631487 ·
Last close
$0.37
Market Cap
$6.96M
52W High
$0.46
52W Low
$0.27
ADV30
73,084
Next earnings
2026-08-19
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 73,000 | -243,000 | -3,115,000 | -3,097,000 | 9,183,000 | 4,262,000 | 4,297,000 |
| Dec 2025 | 60,000 | -132,000 | -3,150,000 | -3,207,000 | 10,785,000 | 5,591,000 | 4,704,000 |
| Sep 2025 | 77,000 | -192,000 | -3,507,000 | -3,483,000 | 14,089,000 | 8,547,000 | 4,784,000 |
| Jun 2025 | 179,000 | -7,000 | -3,178,000 | -3,347,000 | 17,437,000 | 11,434,000 | 4,932,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,419,000
Investing CF
$-27,000
Financing CF
$3,102,000
CapEx
$-28,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.06
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-124,839,000
Inventory
$573,000
Receivables
$224,000
ST Investments
—
EBIT TTM
$-11,483,000
Pretax Income TTM
$-11,489,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$389,000
EBITDA
$-12,072,000
Free Cash Flow
$-6,678,750
Enterprise Value
$3,582,255
Total Cash
$4,262,000
Total Debt
$2,649,000
Shares Out
18,908,207
Trailing EPS
$-1.04
Book Value
$0.34
ROE
-152.0%
ROA
-61.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,371,000 | -11,483,000 | -11,489,000 | 10,785,000 | 4,704,000 | — | -9,419,000 |
| Dec 2024 | 515,000 | -17,251,000 | -16,609,000 | 18,710,000 | 5,245,000 | — | -14,093,000 |
| Dec 2023 | 10,959,000 | -7,512,000 | -7,019,000 | 34,126,000 | 5,786,000 | — | -2,763,000 |
| Dec 2022 | 299,000 | -17,097,000 | -16,925,000 | 37,768,000 | 5,487,000 | — | -13,698,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.39
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NDRA | ENDRA Life Sciences Inc. | $7.13M | $5.61 | — |
| NVNO | enVVeno Medical Corp | $7.58M | $11.36 | — |
| SNOA | Sonoma Pharmaceuticals, Inc. | $6.03M | $1.26 | — |
| XAIR | Beyond Air, Inc. | $6.01M | $0.42 | — |
| VVOS | Vivos Therapeutics, Inc. | $6.00M | $0.43 | — |
News headlines (Yahoo Finance, 1h cache)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT
2026-06-30 12:00 · Yahoo
COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
2026-05-29 11:00 · Yahoo
CollPlant Issues Letter to Shareholders
2026-04-13 11:00 · Yahoo
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
2026-03-26 12:30 · Yahoo
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
2026-03-24 20:01 · Yahoo
CollPlant Biotechnologies Launches Redesigned Corporate Website
2026-03-18 13:00 · Yahoo
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
2026-03-11 12:00 · Yahoo
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
2026-02-26 13:00 · Yahoo
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
2026-02-23 12:00 · Yahoo
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
2026-02-17 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.